Phase III, Randomized, International, Multicenter, Open Label, With Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With Acute Coronary Syndrome With ST Elevation Treated With Pharmacological Thrombolysis
Latest Information Update: 16 May 2022
Price :
$35 *
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms TREAT
- 06 May 2022 Results assessing the impact of morphine on clinical outcomes in Patients with ST segment elevation Myocardial Infarction published in the American Heart Journal
- 18 Mar 2019 Results of a substudy assessing the effect of ticagrelor and clopidogrel on coronary microcirculation in patients with acute myocardial infarction, were presented at the 68th Annual Scientific Session of the American College of Cardiology.
- 18 Mar 2019 According to an AstraZeneca media release, data from this study was presented as a late breaking abstract at the American College of Cardiology's 68th Annual Scientific Session in New Orleans.